Article Details
Retrieved on: 2021-03-25 16:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Updated data from AstraZeneca shows that their COVID-19 vaccine, AZD1222, has 76 percent efficacy against symptomatic infection with the disease.
Article found on: www.medicaleconomics.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here